Metabolic Flashcards
Vitamin deficiency
A, B1 (Thiamine), B3 (Niacin), B6, B9(folic acid), C, D, E, K
A - night-blindness
B1 - Beriberi, Wernicke-Korsakoff syndrome, heart failure, polyneuropathy
B3 - Pellagra 3D (Dermatitis, diarrhoea, dementia)
B6 - anaemia, Irritability, seizure
B9 - Megaloblastic anaemia, neural tube defects
C - scurvy (gingivitis, bleeding)
D - Rickets, osteomalacia
E - peripheral neuropathy, mild haemolytic anaemic in newborn
K - Haemorrhagic disease of newborn, bleeding diathesis
Conn’s syndrome (Primary hyperaldosteronism) features
Hypertension
Hypokalaemia
Metabolic alkalosis
Sodium normal or at the high end of normal
Familial hypercholesterolaemia: what kind of genetic condition
Autosomal dominant
if one parent is affected, arrange testing in children by age 10
if both parents are affected, arrange testing in children by age 5
Obesity classification
BMI Old NICE 25 - 29.9 Overweight Overweight 30 - 34.9 Obese Obese I 35 - 39.9 Clinically obese Obese II > 40 Morbidly obese Obese III
QRISK2 may underestimate the risk in some patients. Which?
patients with a serious mental health disorder and those taking antipsychotics
HIV
autoimmune conditions such as SLE
Statin target lipid fall
40% reduction in non-HDL cholesterol after 3 months
otherwise, increase dose
Statin secondary prevention dose
Atorvastatin 80 mg
Glycemic index of food
High, medium, low
High: white rice, white bread, baked potato
Medium: Couscous, boiled new potato
Low: fruit and vegetables, peanuts
Hyperkalaemia: ECG changes
Tall T, small P, widened QRS
Hyperkalaemia: Causes
AKI Drugs - ACEi, ARB, spironolactone, ciclosporin, heparin Metabolic acidosis Addison's disease Rhabdomyolysis Massive blood transfusion
Best source of Vitamin D
Cod liver oil
Type 1 DM: Should QRISK2 be used?
No. Use the followings
- Older than 40 years
- Had DM for more than 10 years
- Established nephropathy
- Have other CVD risk factors
Food with high potassium
bananas, oranges, kiwi fruit, avocado, spinach, tomatoes
Statin and pregnancy
Statins should be discontinued in women 3 months before conception due to the risk of congenital defects
Hypercalcaemia first-line management
IV fluid, rehydration